Parnax Lab

Parnax Lab EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Parnax Lab (506128.BO) as of Nov 18, 2026 is 15.43. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -13.42 — a change of -215.00% (higher).

EV/FCF

15.43

YoY

-215.00%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Parnax Lab is 2025 15.43 . EV/FCF (Enterprise Value to Free Cash Flow) of Parnax Lab was 2024 -13.42 . It decreases by -215.00% higher compared to the previous year.

The Parnax Lab EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
23.23 INR
Jan 1, 2019
-70.68 INR
Jan 1, 2020
-43.44 INR
Jan 1, 2021
-866.75 INR
Jan 1, 2022
-22.20 INR
Jan 1, 2023
20.37 INR
Jan 1, 2024
-13.42 INR
Jan 1, 2025
15.43 INR
The Parnax Lab EV/FCF history
YEAREV/FCFYoY
15.43-215.00%
-13.42-165.85%
20.37-191.78%
-22.20-97.44%
-866.75+1,895.27%
-43.44-38.54%
-70.68-404.23%
23.23-91.98%
289.58-470.25%
-78.21+51.09%
-51.77+52.58%
-33.93—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

EV/FCF (Enterprise Value to Free Cash Flow) of Parnax Lab is 15.43 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Parnax Lab changed from -13.42 to 15.43, representing a -215.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Parnax Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Parnax Lab

All Key Metrics — Parnax Lab